PD23-08: Results of a prospective, single-center phase-II study on modern androgen deprivation therapy followed by cytoreductive radical prostatectomy in men with de novo metastatic hormone-sensitive prostate cancer (mHSPC)

PD23-08: Results of a prospective, single-center phase-II study on modern androgen deprivation therapy followed by cytoreductive radical prostatectomy in men with de novo metastatic hormone-sensitive prostate cancer (mHSPC)

Sunday, May 17, 2026 4:26 PM to 4:34 PM · 8 min. (America/New_York)
206
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!